Home>Topics>Stocks>PDL BioPharma

PDL BioPharma PDLI

  1. All
  2. Commentary
  3. Headlines
    1. Cramer's Lightning Round - SunPower Has Staying Power (5/15/13)

      Headlines

      Thu, 16 May 2013

      Solar is turning positive. SunPower has staying power. I like First Solar more. It has true profitability." PDL BioPharma ( PDLI ): "It is a spec, but I like this one." Ford ( F ) : "I think Europe is bottoming. Ford is a buy." Berkshire

    2. PDL BioPharma CEO Discuses Q1 2013 Results - Earnings Call Transcript

      Headlines

      Thu, 9 May 2013

      PDL BioPharma Inc. ( PDLI ) Q1 2013 Earnings Call May 9 ..... Good afternoon and welcome to the PDL BioPharma ’s First Quarter 2013 Earnings Conference ..... seekingalpha.com/article/1421991- pdl - biopharma -ceo-discuses-q1-2013-results

    3. PDL Biopharma ( PDLI ): Q1 EPS of $0.36 in line. Revenue of $91.8M (+19% Y/Y) beats by $110K. (PR). Shares +2% AH.

      Headlines

      Thu, 9 May 2013

      PDL Biopharma ( PDLI ): Q1 EPS of $0.36 in line. Revenue of $91.8M (+19% Y/Y) beats by $110K . ( PR ). Shares +2% AH. Post your comment!

    4. Whisper Number Impact: Earnings Preview For PDL BioPharma

      Headlines

      Thu, 9 May 2013

      By WhisperNumber : PDL BioPharma ( PDLI ) is expected to report earnings after the close on Thursday ..... Whisper numbers range from a low of $0.40 to a high of $0.45. PDLI has a 63% positive surprise history, having topped the whisper

    5. PDLI

      Commentary

      Thu, 2 May 2013

      Looking for opinions on PDLI . Good purchase price? Is the dividend safe? What happens when the patents expire in 2014? Thanks. Roger

    6. 3 Healthcare Stocks With Greater Than 4% Dividend Yields To Inject Life Into Your Portfolio

      Headlines

      Wed, 10 Apr 2013

      By Black Coral Research : Big pharmaceutical stocks have been losing their shine among investors seeking high-growth investments. The sector is witnessing fewer new blockbuster drugs along with the headwinds from efforts to limit healthcare spending globally. Despite this, the pharma sector ...

    7. Rovi Corporation: A Case Study In The Value Of Intellectual Property

      Headlines

      Tue, 12 Mar 2013

      STRFKR record, to the humanization of antibodies patents (known as the Queen, et. al. patents) awarded to PDL BioPharma ( PDLI ). Even this article is IP: it is my original work, and I have granted its publisher an exclusive license to

    8. PDL BioPharma's CEO Discusses Q4 2012 Results - Earnings Call Transcript

      Headlines

      Fri, 1 Mar 2013

      PDL BioPharma , Inc. ( PDLI ) Q4 2012 Earnings Conference Call ..... and gentlemen and welcome to the PDL BioPharma ’s Fourth Quarter 2012 Earnings Conference ..... seekingalpha.com/article/1241781- pdl - biopharma -s-ceo-discusses-q4-2012

    9. PDL BioPharma Inc. ( PDLI ): Q4 EPS of $0.34 beats by $0.03. Revenue of $86M in-line. (PR)

      Headlines

      Fri, 1 Mar 2013

      PDL BioPharma Inc. ( PDLI ): Q4 EPS of $0.34 beats by $0.03 . Revenue of $86M in-line. ( PR ) Post your comment!

    10. Notable earnings after Friday’s close: [[ PDLI ]], [[STEC]], [[VECO]], [[VNR]]

      Headlines

      Fri, 1 Mar 2013

      Notable earnings after Friday’s close: PDLI , STEC , VECO , VNR Post your comment!

    « Prev12345Next »
    Content Partners